CClinicalTrials.gg
Status unknownNCT04256694Updated Sep 3, 2020

Rapid Strep Test Results

An observational study in Strept Throat, sponsored by Kendall Healthcare Group, Ltd.. Status unknown at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-09-03.

Sponsored by Kendall Healthcare Group, Ltd. · Observational

The sponsor has not verified this record recently (last verified Sep 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective study seeks to determine how often a rapid antigens test for group A streptococcus is positive in healthy adults

Read the detailed description

The Unites States recommends the use of rapid antigen tests, but a number of other countries do not, citing a high prevalence of streptococcal carriers and only moderate sensitivity of rapid antigen tests [1]. Indeed, to fully understand when rapid antigen tests should be used, we need to know the streptococcal carrier rate for adults in the United States. Although there is a fair amount of data in this regard for children [2,3], the only study to report this value for adults was from over 20 years ago and was from Sweden [4]. That studied reported a Group A Streptococcus (GAS) carrier rate of 2.4-3.7% in healthy adults.

Given how many patients seek medical care for sore throats that may potentially be streptococcal pharyngitis, the investigators believe more data about the GAS carrier rate and the rate of false positive rapid antigen tests is necessary. Thus, the investigators propose a prospective study to evaluate the rate of positive rapid antigen tests in healthy adult patients in our community.

The investigators will perform rapid antigen tests for GAS on healthy adult subjects without any symptoms. Consenting patients will fill out a brief data collection form about their medical history, and an investigator will perform a rapid antigen throat swab to assess for GAS. The results of the rapid antigen test will be recorded, and a logistic regression analysis will be performed to determine if certain factors within the subject's medical history are predictive of positive rapid strep tests.

02

Conditions studied

  • Strept Throat

Keywords

  • Carrier rate
  • Rapid antigen test
03

In context

Lead sponsor

Kendall Healthcare Group, Ltd. is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy volunteers, primarily from subjects known to the investigators.

Inclusion criteria

  • Any person at least 18 years old

Exclusion criteria

Exclusion Criteria:

  • pregnant
  • prisoners
  • currently taking antibiotics
  • any acute symptoms
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthy Adult Subjects

    Diagnostic Test: Rapid Antigen Test for Group A Streptococcus

Interventions

  • Diagnostic testRapid Antigen Test for Group A Streptococcus

    Rapid strep tests will be performed by throat swab of healthy adult volunteers.

06

What researchers measure

Primary outcomes

  1. % Positive Rapid Antigen Strep Tests

    % of positive rapid antigen strep tests amongst all volunteers

    Time frame: The throat will be swabbed, and the swab will be immediately analyzed. The results are available after five minutes.

Secondary outcomes

  1. Predictors of Positive Strep Tests

    Logistic regression analysis will assess if any of the following are significant predictors of positive strep tests: age, gender, race/ethnicity, chronic medical problems, whether or not the patient has had antibiotics within last month, whether or not they have a history of strep throat, and whether or not they are a medical student or healthcare professional.

    Time frame: After enrollment of all subjects, a logistic regression analysis will be performed.

07

Study locations

1 of 1 sites recruiting
  • Kendall Regional Medical Center
    Miami, Florida 33175, United States
    Recruiting
08

References and documents

Publications

  • Matthys J, De Meyere M, van Driel ML, De Sutter A. Differences among international pharyngitis guidelines: not just academic. Ann Fam Med. 2007 Sep-Oct;5(5):436-43. doi: 10.1370/afm.741. PubMed 17893386 ↗
  • Shaikh N, Leonard E, Martin JM. Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics. 2010 Sep;126(3):e557-64. doi: 10.1542/peds.2009-2648. Epub 2010 Aug 9. PubMed 20696723 ↗
  • Oliver J, Malliya Wadu E, Pierse N, Moreland NJ, Williamson DA, Baker MG. Group A Streptococcus pharyngitis and pharyngeal carriage: A meta-analysis. PLoS Negl Trop Dis. 2018 Mar 19;12(3):e0006335. doi: 10.1371/journal.pntd.0006335. eCollection 2018 Mar. PubMed 29554121 ↗
  • Gunnarsson RK, Holm SE, Soderstrom M. The prevalence of beta-haemolytic streptococci in throat specimens from healthy children and adults. Implications for the clinical value of throat cultures. Scand J Prim Health Care. 1997 Sep;15(3):149-55. doi: 10.3109/02813439709018506. PubMed 9323783 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04256694
Lead sponsor
Kendall Healthcare Group, Ltd.
Collaborators
Florida International University
Responsible party
Sponsor
First posted
Feb 5, 2020
Start date
Feb 5, 2020
Primary completion
Apr 30, 2021 (estimated)
Completion
Apr 30, 2021 (estimated)
Last update
Sep 3, 2020

Study contacts

Tony Zitek, MD
Contact
zitek10@gmail.com
305-480-6602
Tony Zitek, MD
principal investigator · Kendall Healthcare Group, Ltd.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion